The pathogenesis of Staphylococcus aureus in the trauma patient and potential future therapies (Q40929246)

24 September 2017

1 reference

title

The pathogenesis of Staphylococcus aureus in the trauma patient and potential future therapies (English)

1 reference

24 September 2017

main subject

Staphylococcus aureus

1 reference

Villavicencio RT

1

1 reference

24 September 2017

Wall MJ Jr

series ordinal

2

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 September 1996

1 reference

The American Journal of Surgery

24 September 2017

published in

1 reference

24 September 2017

volume

172

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

291-296

1 reference

Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

MSCRAMM-mediated adherence of microorganisms to host tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Microbial adhesins recognizing extracellular matrix macromolecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Identification of the ligand-binding domain of the surface-located fibrinogen receptor (clumping factor) of Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Staphylococcus aureus expresses a major histocompatibility complex class II analog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Cellular studies on antigen presentation by class II MHC molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Antibody response to Staphylococcus aureus collagen binding protein in patients with S. aureus septicaemia and collagen binding properties of corresponding strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

The vascular endothelium. A new horizon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Production of tumor necrosis factor by human monocytes in response to toxic-shock-syndrome toxin-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Glycerol monolaurate inhibits the production of beta-lactamase, toxic shock toxin-1, and other staphylococcal exoproteins by interfering with signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Neutrophil function in surgical patients. Relationship to adequate bacterial defenses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Sepsis in the critically ill patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Enhancement of in vitro bactericidal activity of neutrophils from trauma patients in the presence of granulocyte colony-stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Can antibiotic resistance be controlled?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Antibiotics that resist resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

In vivo therapeutic efficacies of PD 138312 and PD 140248, two novel fluoronaphthyridines with outstanding gram-positive potency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

New mechanisms of bacterial resistance to antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Penicillin-binding proteins and bacterial resistance to beta-lactams

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Inducible NorA-mediated multidrug resistance in Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Prevention of vascular graft infection by sisomicin incorporated into fibrin glue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Intravenous and central catheter infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Methicillin-resistant Staphylococcus aureus as a community organism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Antibiotics and prevention of microbial colonization of catheters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Growth of Staphylococcus aureus with nafcillin in vitro induces alpha-toxin production and increases the lethal activity of sterile broth filtrates in a murine model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Antibacterial activity of flavanostilbenes against methicillin-resistant Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Increased Resistance to Staphylococcus aureus Infection and Enhancement in Serum Lysozyme Activity by Glucan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Internalization of Staphylococcus aureus by endothelial cells induces cytokine gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

Cloning, expression, and nucleotide sequence of a Staphylococcus aureus gene (fbpA) encoding a fibrinogen-binding protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

7 January 2021

Identification of a Staphylococcus aureus extracellular matrix-binding protein with broad specificity.

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

7 January 2021

Capsular polysaccharide types 5 and 8 of Staphylococcus aureus bind specifically to human epithelial (KB) cells, endothelial cells, and monocytes and induce release of cytokines

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

7 January 2021

Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

7 January 2021

Interaction of the two components of leukocidin from Staphylococcus aureus with human polymorphonuclear leukocyte membranes: sequential binding and subsequent activation

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

7 January 2021

Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

7 January 2021

Staphylococcus aureus toxic shock syndrome toxin 1 and Streptococcus pyogenes erythrogenic toxin A modulate inflammatory mediator release from human neutrophils.

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

7 January 2021

Staphylococcal toxic shock syndrome toxin 1-induced tumor necrosis factor alpha and interleukin-1 beta secretion by human peripheral blood monocytes and T lymphocytes is differentially suppressed by protein kinase inhibitors.

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

7 January 2021

The Differential Response to Infection of Autogenous Vein versus Dacron Arterial Prosthesis

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

7 January 2021

Differential effects of monoclonal antibody blockade of adhesion molecules on in vivo susceptibility to soft tissue infection

1 reference

https://api.crossref.org/works/10.1016/S0002-9610(96)00102-X

7 January 2021

10.1016/S0002-9610(96)00102-X

Identifiers

DOI

1 reference

24 September 2017

1 reference